TrialThe Journal of antimicrobial chemotherapy2014
The pyrazinamide susceptibility breakpoint above which combination therapy fails.
Tawanda Gumbo et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
40 papers cite it
this papertrialcites it